Georgios Lyratzopoulos on the NAEDI and the Ca-PRI conferences, 2013
22 Apr, 13 | by BMJ Group
In retrospect, 1999 could be seen as the low point for cancer control policy in the UK. In that year, the Eurocare 2 study showed that the survival of patients with cancer was lower in the UK than several other European countries with similar healthcare systems. This finding has since been replicated by much further research—which thankfully also demonstrated continuous improvements in UK survival rates. In the same year, we also learned that cancer survival varies notably between patients living in richer and poorer neighbourhoods of England and Wales. This convinced even the most sceptical members of the academic community (and the most patriotic UK media) that something needed to be done. more…


